Item 7.01. Regulation FD Disclosure.

On January 9, 2023, Rhythm Pharmaceuticals, Inc. (the "Company") posted a corporate slide presentation in the "Investors & Media" portion of its website at ir.rhythmtx.com. A copy of its current corporate slide presentation is attached to this Current Report on Form 8-K as Exhibit 99.1. The Company undertakes no obligation to update, supplement or amend the materials attached hereto as Exhibit 99.1.

The information contained in Item 7.01 of this Form 8-K (including Exhibit 99.1 attached hereto) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly provided by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.






(d) Exhibits

The following Exhibit 99.1 relating to Item 7.01 shall be deemed to be furnished, and not filed:





Exhibit No.                                Description

  99.1          Corporate Slide Presentation of Rhythm Pharmaceuticals, Inc. dated
              January 9, 2023
104           Cover Page Interactive Data File (embedded within the inline XBRL
              document)

© Edgar Online, source Glimpses